1. 目前位置：

瀏覽 的方式： 關鍵字 DAA

跳到： 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
或是輸入前幾個字：  
顯示 1 到 7 筆資料，總共 7 筆
公開日期標題作者
1-十一月-2019APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivationKanda, Tatsuo; Lau, George K. K.; Wei, Lai; Moriyama, Mitsuhiko; Yu, Ming-Lung; Chuang, Wang-Long; Ibrahim, Alaaeldin; Lesmana, Cosmas Rinaldi Adithya; Sollano, Jose; Kumar, Manoj; Jindal, Ankur; Sharma, Barjesh Chander; Hamid, Saeed S.; Dokmeci, A. Kadir; Mamun-Al-Mahtab; McCaughan, Geoffrey W.; Wasim, Jafri; Crawford, Darrell H. G.; Kao, Jia-Horng; Ooka, Yoshihiko; Yokosuka, Osamu; Sarin, Shiv Kumar; Omata, Masao; 生物科技學院; College of Biological Science and Technology
1-一月-1970Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradicationHuang, Chung-Feng; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Ching-, I; Lee, Hsiang-Chun; Lai, Wen-Ter; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung; 生物科技學院; College of Biological Science and Technology
1-七月-2020Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infectionYeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-, I; Holmes, Jacinta A.; Hsieh, Meng-Hsuan; Tsai, Yi-Shan; Liang, Po-Cheng; Tsai, Pei-Chien; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Chung, Raymond T.; Yu, Ming-Lung; 交大名義發表; 生物科技學系; National Chiao Tung University; Department of Biological Science and Technology
1-一月-1970Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agentsJang, Tyng-Yuan; Huang, Ching-, I; Yeh, Ming-Lun; Liang, Po-Cheng; Tsai, Pei-Chien; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung; 交大名義發表; 生物科技學系; National Chiao Tung University; Department of Biological Science and Technology
15-八月-2019An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated SubstitutionsHuang, Chung-Feng; Hung, Chao-Hung; Cheng, Pin-Nan; Bair, Ming-Jong; Huang, Yi-Hsiang; Kao, Jia-Horng; Hsu, Shih-Jer; Lee, Pei-Lun; Chen, Jyh-Jou; Chien, Rong-Nan; Peng, Cheng-Yuan; Lin, Chun-Yen; Hsieh, Tsai-Yuan; Cheng, Chun-Han; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung; 交大名義發表; 生醫工程研究所; National Chiao Tung University; Institute of Biomedical Engineering
1-一月-1970Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevirHuang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-, I; Liang, Po-Cheng; Lin, Yi-Hun; Hsieh, Ming-Yen; Chen, Kuan-Yu; Ko, Yu-Min; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung; 交大名義發表; 生物科技學系; National Chiao Tung University; Department of Biological Science and Technology
1-一月-2017Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developmentsHuang, Chung-Feng; Yu, Ming-Lung; 生物科技學院; College of Biological Science and Technology
顯示 1 到 7 筆資料，總共 7 筆